Pharmidex is pleased to announce our participation in the "Drug Safety Forum 2024" happening on Thursday, 17th October in London! 🏙️

Our Business Development representative, Mohammed Yaqoob, will be attending and is eager to connect with other participants during the event. This forum, focused on a patient-first approach to drug safety from nonclinical to clinical stages, aligns with our commitment to advancing safe and effective treatments.

If you're attending, be sure to stop by and chat with Mo to explore how Pharmidex can support your drug development journey. He looks forward to engaging with fellow professionals and discussing opportunities for collaboration. 🤝